Edition:
India

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Capital Market

0.56USD
22 Jan 2019
Change (% chg)

$-0.03 (-4.34%)
Prev Close
$0.59
Open
$0.58
Day's High
$0.58
Day's Low
$0.56
Volume
12,918
Avg. Vol
61,741
52-wk High
$1.25
52-wk Low
$0.28

Chart for

About

Genocea Biosciences, Inc., is harnessing the power of T cell immunity to develop vaccines and immunotherapies company. The Company uses its discovery platform, AnTigen Lead Acquisition System (ATLAS), to design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses. The Company has one... (more)

Overall

Beta: 2.01
Market Cap(Mil.): $50.18
Shares Outstanding(Mil.): 28.67
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates